Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lupus and its management

D M Fagundus1, E C Leroy

  • 1Department of Medicine, MUSC, Charleston 29425-2229.

Journal of the South Carolina Medical Association (1975)
|November 1, 1993
PubMed
Summary
This summary is machine-generated.

Systemic lupus erythematosus (SLE) management parallels other chronic diseases, emphasizing early evaluation and monitoring to prevent complications. Minimizing steroids and using cytotoxic agents cautiously can decrease SLE mortality.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Association between polymorphic variation in VDR and RXRA and circulating levels of vitamin D metabolites.

The Journal of steroid biochemistry and molecular biology·2010
Same author

The 72-kilodalton IE-1 protein of human cytomegalovirus (HCMV) is a potent inducer of connective tissue growth factor (CTGF) in human dermal fibroblasts.

Clinical and experimental rheumatology·2004
Same author

A profibrotic polymorphism (of TGFbeta1) in systemic sclerosis.

Annals of the rheumatic diseases·2002
Same author

Anti-fibrillin-1 autoantibodies in systemic sclerosis are GM and KM allotype-restricted.

Experimental and clinical immunogenetics·2001
Same author

MCMV induces neointima in IFN-gammaR-/- mice: intimal cell apoptosis and persistent proliferation of myofibroblasts.

BMC musculoskeletal disorders·2001
Same author

Criteria for the classification of early systemic sclerosis.

The Journal of rheumatology·2001
Same journal

Long Term Strenuous Exercise: Is There a Dose Effect?

Journal of the South Carolina Medical Association (1975)·2018
Same journal

Dosing Exercise for Longevity: How Much is Enough and How Much is Too Much?

Journal of the South Carolina Medical Association (1975)·2018
Same journal

Sudden Cardiac Death in School Aged Athletes.

Journal of the South Carolina Medical Association (1975)·2018
Same journal

Prevention Matters.

Journal of the South Carolina Medical Association (1975)·2016
Same journal

Tropical Pyomyositis in a Temperate Climate.

Journal of the South Carolina Medical Association (1975)·2016
Same journal

The Cost of Hope in Terminal Illness.

Journal of the South Carolina Medical Association (1975)·2016
See all related articles

Area of Science:

  • Rheumatology
  • Immunology
  • Internal Medicine

Background:

  • Systemic lupus erythematosus (SLE) is a chronic autoimmune disease requiring long-term management.
  • Effective SLE treatment necessitates an approach similar to managing other chronic conditions.

Observation:

  • Early and thorough patient evaluation is crucial for identifying SLE.
  • Regular monitoring for silent manifestations, such as renal involvement, is vital to prevent severe complications.
  • Treatment for non-life-threatening SLE should align with standard care for non-lupus patients, prioritizing steroid minimization.

Findings:

  • The judicious use of cytotoxic agents is instrumental in reducing SLE mortality rates.
  • Careful administration of these agents, in consultation with a rheumatologist, is essential.

Related Experiment Videos

Implications:

  • Optimized SLE management can significantly improve patient outcomes and reduce disease-related morbidity.
  • Minimizing steroid use and employing cytotoxic agents strategically are key to managing SLE effectively and safely.